Michael Skynner

CIK: 0001776582

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)17 (85.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (15.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BCYC

BICYCLE THERAPEUTICS PLC

Officer

Discretionary Trading P&L

Holdings

Transaction History (20 total)

BCYC
BICYCLE THERAPEUTICS PLC
Oct 5, 2026
Sale(S)
Direct
503 shares at avg. $3.57$2K
BCYC
BICYCLE THERAPEUTICS PLC
Oct 2, 2026
Sale(S)
Direct
1.9K shares at avg. $3.47$7K
BCYC
BICYCLE THERAPEUTICS PLC
Jul 15, 2026
Award(A)
Employee Stock Option (right to buy)
Direct
60K shares-
BCYC
BICYCLE THERAPEUTICS PLC
Jul 6, 2026
Sale(S)
Direct
532 shares at avg. $4.31$2K
BCYC
BICYCLE THERAPEUTICS PLC
Jul 2, 2026
Sale(S)
Direct
1.9K shares at avg. $4.27$8K
BCYC
BICYCLE THERAPEUTICS PLC
Apr 6, 2026
Sale(S)
Direct
525 shares at avg. $5.05$3K
BCYC
BICYCLE THERAPEUTICS PLC
Apr 2, 2026
Sale(S)
Direct
1.9K shares at avg. $4.91$9K
BCYC
BICYCLE THERAPEUTICS PLC
Jan 5, 2026
Sale(S)
Direct
3.3K shares at avg. $6.46$21K
BCYC
BICYCLE THERAPEUTICS PLC
Jan 2, 2026
Sale(S)
Direct
3K shares at avg. $6.80$21K
BCYC
BICYCLE THERAPEUTICS PLC
Jan 2, 2026
Award(A)
Direct
50K shares-
BCYC
BICYCLE THERAPEUTICS PLC
Oct 3, 2025
Sale(S)
Direct
978 shares at avg. $8.41$8K
BCYC
BICYCLE THERAPEUTICS PLC
Oct 2, 2025
Sale(S)
Direct
824 shares at avg. $8.40$7K
BCYC
BICYCLE THERAPEUTICS PLC
Jul 3, 2025
Sale(S)
Direct
966 shares at avg. $7.44$7K
BCYC
BICYCLE THERAPEUTICS PLC
Jul 2, 2025
Sale(S)
Direct
825 shares at avg. $7.09$6K
BCYC
BICYCLE THERAPEUTICS PLC
Apr 3, 2025
Sale(S)
Direct
1K shares at avg. $7.48$8K
BCYC
BICYCLE THERAPEUTICS PLC
Apr 2, 2025
Sale(S)
Direct
814 shares at avg. $8.02$7K
BCYC
BICYCLE THERAPEUTICS PLC
Jan 3, 2025
Sale(S)
Direct
936 shares at avg. $14.75$14K
BCYC
BICYCLE THERAPEUTICS PLC
Jan 2, 2025
Award(A)
Direct
35K shares-
BCYC
BICYCLE THERAPEUTICS PLC
Jan 2, 2025
Sale(S)
Direct
3.3K shares at avg. $14.09$46K
BCYC
BICYCLE THERAPEUTICS PLC
Oct 3, 2024
Sale(S)
Direct
972 shares at avg. $22.26$22K

		Type	Shares	Price		Ownership
Oct 5, 2026	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	503	$3.57	$1,796	Direct
Oct 2, 2026	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	1,942	$3.47	$6,739	Direct
Jul 15, 2026	BCYC BICYCLE THERAPEUTICS PLC	Award(A) Employee Stock Option (right to buy)	60,000	-	-	Direct
Jul 6, 2026	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	532	$4.31	$2,293	Direct
Jul 2, 2026	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	1,859	$4.27	$7,938	Direct
Apr 6, 2026	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	525	$5.05	$2,651	Direct
Apr 2, 2026	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	1,879	$4.91	$9,226	Direct
Jan 5, 2026	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	3,266	$6.46	$21,098	Direct
Jan 2, 2026	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	3,045	$6.80	$20,706	Direct
Jan 2, 2026	BCYC BICYCLE THERAPEUTICS PLC	Award(A)	50,000	-	$0	Direct
Oct 3, 2025	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	978	$8.41	$8,225	Direct
Oct 2, 2025	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	824	$8.40	$6,922	Direct
Jul 3, 2025	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	966	$7.44	$7,187	Direct
Jul 2, 2025	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	825	$7.09	$5,849	Direct
Apr 3, 2025	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	1,038	$7.48	$7,764	Direct
Apr 2, 2025	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	814	$8.02	$6,528	Direct
Jan 3, 2025	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	936	$14.75	$13,806	Direct
Jan 2, 2025	BCYC BICYCLE THERAPEUTICS PLC	Award(A)	35,000	-	$0	Direct
Jan 2, 2025	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	3,287	$14.09	$46,314	Direct
Oct 3, 2024	BCYC BICYCLE THERAPEUTICS PLC	Sale(S)	972	$22.26	$21,637	Direct

1-20 of 20 transactions

About Skynner Michael

Skynner Michael (SEC CIK 0001776582) files insider reports with the SEC as CHIEF SCIENTIFIC OFFICER of BICYCLE THERAPEUTICS PLC (BCYC).

Signal8 holds 10 ownership filings by Skynner Michael, all Form 4s, filed between Oct 4, 2024 and Oct 6, 2026. Those filings report 20 transactions, from Oct 3, 2024 to Oct 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Skynner Michael's filings is in CAMBRIDGE.

Recent filings by Skynner Michael

Oct 5, 2026: Open-market sale of BCYC shares (Form 4, code S).
Oct 2, 2026: Open-market sale of BCYC shares (Form 4, code S).
Jul 15, 2026: Grant or award of BCYC derivative securities (Form 4, code A).
Jul 6, 2026: Open-market sale of BCYC shares (Form 4, code S).
Jul 2, 2026: Open-market sale of BCYC shares (Form 4, code S).

Other insiders filing for BICYCLE THERAPEUTICS PLC (BCYC)

Perry Jennifer Scott, Chief Operating Officer
Swanton Robert Charles, Director
Hannay Michael Charles Ferguson, CHIEF PROD & SUPPLY CHAIN OFF
Lee Kevin, CHIEF EXECUTIVE OFFICER
Thompson Travis Alvin, Chief Financial Officer
Milnes Alistair, CHIEF OPERATING OFFICER

How to read Form 4 transaction codes